Verastem (VSTM)
(Delayed Data from NSDQ)
$10.90 USD
+0.54 (5.21%)
Updated May 3, 2024 04:00 PM ET
After-Market: $10.90 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Brokerage Reports
Verastem, Inc. [VSTM]
Reports for Purchase
Showing records 61 - 80 ( 264 total )
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for VSTM.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Eyes on Key Clinical Readouts in Q2 and 2H22; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for VSTM.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for VSTM.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for VSTM.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Focus is on RAMP Study Readouts; Financial Overhang Removed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for VSTM.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for VSTM.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended February 11.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for VSTM.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for VSTM.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for VSTM.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended December 17
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended December 10
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Mirati Collaboration Is Another Vote of Confidence in VS-6766; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Looking Ahead to RAMP Interim Readouts in 1H22; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Update at ESMO Continues to Support Benefit in LGSOC; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Upcoming Clinical Update at ESMO; Debt Converted; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Debt Overhang Removed Through Conversion; Higher $5.00 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S